Abstract
Key words: cardiotoxicity, diagnostics, exogenous phosphocreatine, cardioprotection, treatment tactics.
For citation:Pylev A.L., Lisovoy V.A., Kozlova O.S. A clinical case of cardioprotective therapy with exogenous phosphocreatine during chemotherapy and anti HER2-neu therapy in a patient with breast cancer. Clinical review for general practice. 2023; 4 (12): 20–24 (In Russ.). DOI: 10.47407/kr2023.4.12.00325
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.